TGF-β1 inhibitor enhances the therapeutic effect of microwave ablation on hepatocellular carcinoma
Background Microwave ablation (MWA) is a widely adopted treatment technique for hepatocellular carcinoma (HCC). However, MWA alone is of limited use and has a high recurrence rate. Transforming growth factor-β1 (TGF-β1) is recognized as a potential therapeutic target for HCC patients. Therefore, thi...
Saved in:
| Main Authors: | Shufang Xiang, Juan Li, Mei Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | International Journal of Hyperthermia |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/02656736.2024.2359496 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative Analysis of Radiofrequency Ablation and Microwave Ablation for Critically Located Hepatocellular Carcinomas Smaller than 5 cm
by: Ravindran Ramalingam, et al.
Published: (2021-01-01) -
Can Tumor Recurrence Be Predicted by Magnetic Resonance Imaging Findings Before Microwave Ablation in Patients with Hepatocellular Carcinoma?
by: Mustafa Özdemir
Published: (2024-09-01) -
Y90 Radiation Segmentectomy versus Microwave Ablation for Hepatocellular Carcinoma in Locations Suboptimal for Percutaneous Ablation
by: Olivia Kola, et al.
Published: (2025-01-01) -
Microwave ablation vs. liver resection for patients with hepatocellular carcinomas
by: Hyundam Gu, et al.
Published: (2025-03-01) -
Clinical features and risk factors for pelvic metastasis after microwave ablation of hepatocellular carcinoma: a nested case–control study
by: Chao-Nan Chen, et al.
Published: (2025-12-01)